Is Advicenne SA halal to invest in?

According to Musaffa's Shariah screening methodology, Advicenne SA (ALDVI.PA) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Advicenne SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Advicenne SA using these criteria to determine its compliance status.

Can Muslims buy shares of Advicenne SA?

Muslim investors may consider investing in Advicenne SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Advicenne SA classified as NOT HALAL?

Musaffa determines the Shariah status of Advicenne SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Advicenne SA updated?

The Shariah compliance status of Advicenne SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Advicenne SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Advicenne SA?

You can check the latest Shariah compliance status of Advicenne SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Advicenne SA ALDVI.PA

€0.87 €0.09 (9.08%) 1D

Last Updated: May 15, 12:00 AM·XPAR

ALDVI.PA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 25, 2025

Report Source: 2024 Annual Report

Analyst's Ratings for Advicenne SA (ALDVI.PA)

Based on 9 analysts giving stock ratings to Advicenne SA in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Advicenne SA. Stock Analysis ALDVI.PA

France Health Care Nano Cap Report: 2024 Annual

Advicenne SA is a pharmaceutical company, which engages in the development of innovative treatments in Nephrology. The company is headquartered in Paris, Ile-De-France and currently employs 14 full-time employees. The company went IPO on 2017-12-06. The firm focuses on the development of paediatric friendly therapeutics for the treatment of orphan renal diseases and niche neurology indications. The Company’s medicines are developed for patients of all ages in the fields of nephrology and neurology. Its lead product includes ADV7103, which is in phase III, designed to address dRTA both in children for whom the disease is genetic as well as for adults who may have acquired the condition as a result of autoimmune disease. Apart from its lead product, the Company also develops a portfolio of products, including ADV6209, which is an oral liquid solution for moderate sedation; Likozam, which is designed to meet the unmet medical need of patients with partial and generalized chronic refractory epilepsy; Levidcen, which is used to address the unmet medical need of epileptic patients with partial onset seizures, and ADV7103 Cystinuria, among others.

Key Statistics of Advicenne SA (ALDVI.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€0.87€0.96

Today's Open

€0.96

Volume

146.39K

P/E Ratio (TTM)

52 Week Range

€0.80€2.35

Market Cap

17.91M

Avg. Volume

19.12K

Dividend Yield

Financial Metrics & Statements of Advicenne SA (ALDVI.PA)

FAQ's for Advicenne SA (ALDVI.PA)

According to Musaffa’s Shariah screening methodology, Advicenne SA (ALDVI.PA) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.